Previous 10 | Next 10 |
2023-03-06 10:53:35 ET Therapeutic Solutions International ( OTCPK:TSOI ) said it plans to start a 10-patient proof-of-concept trial via Res Nova Bio subsidiary aimed at showing the ability of FloraStilbene to stimulate the immune system in patients with advanced breast ...
Company Receives Institutional Review Board Approval for 10 Patient Proof of Concept Oncology Trial Therapeutic Solutions International (TSOI) announced today plans to initiate ten patient proof-of-concept clinical trial aimed at demonstrating the ability of FloraStilbene™ to sti...
Therapeutic Solutions International Announces Positive Preclinical Results in “Patient Ready” FloraVax Therapy Therapeutic Solutions International (TSOI) announced today paradigm shifting findings leveraging the age-old immunological paradigm that cancer is an uncontrolled...
Breast Cancer Angiogenesis Targeting Immunotherapy Company Aims for a Cure without Toxicity of Conventional Therapies Therapeutic Solutions International (TSOI) announced today the recruitment of Ms. Famela Ramos as Chief Executive Officer of Res Nova Bio, Inc., as well as formation of ...
Therapeutic Solutions International (TSOI) announced today an update on progress made by its subsidiary Campbell Neurosciences, Inc. Campbell was founded on the principle that suicide in numerous situations is a result of biological factors that can be diagnosed and addressed using medical ap...
New Finding May Facilitate Personalized Stem Cell Therapy Therapeutic Solutions International (TSOI) announced today identification and patent filing of a previously unexpected discovery that responsiveness to JadiCell stem cell therapy appears to correlate with alternations of a specif...
Secondary Finding Demonstrates Tattooing Skin with Tolerogenic Genes AIRE or FoxP3 “Balances” Immune System to Stop Autoimmunity Therapeutic Solutions International (TSOI) announced novel data and patent filing today on the unanticipated finding that multiple microinjectio...
Phase III Adult Stem Cell Company Reports Positive Data Through “Right to Try” Accelerated Access Collaboration Therapeutic Solutions International (TSOI) announced today preliminary results of a collaboration with the Veltmeyer Institute for Advanced Therapeutics aimed at...
Phase III Adult Stem Cell Company Covers Ability of its COVID-19 Nutraceutical to Repair Injured Brain Cells and Stimulate Endogenous Brain Stem Cells Therapeutic Solutions International (TSOI) announced today issuance of United States Patent # 11,504,410 1 which in its ...
Breathe Biologics Inc., a Pulmonary Regenerative Medicine Subsidiary of TSOI, Discloses Allogeneic Pulmonary Myeloid Suppressor Cell Based Product Therapeutic Solutions International (TSOI) announced today new data, licensing, and patent filing on a novel cellular therapy fo...
News, Short Squeeze, Breakout and More Instantly...
Therapeutic Sltns Intl Company Name:
TSOI Stock Symbol:
OTCMKTS Market:
Therapeutic Sltns Intl Website:
Clinical Stage Stem Cell Company Granted Exclusivity on the Use of Specific Immune System Cells to Increase Efficacy of Stem Cells in Lung Inflammation Therapeutic Solutions International, Inc. (TSOI) announced today receipt of a Notice of Allowance from the United States Patent and Tra...
Therapeutic Solutions International Pre-Spin-Off Company Plans to Enter Capital Markets Through Partial Distribution of its Shares to Shareholders of Parent Company Therapeutic Solutions International, Inc. (TSOI) Pre-Spin-Off Company Plans to Enter Capital Markets Through Partial Distr...
Latest Patent to Complement Issued Claims on Viral Inhibition, Adaptive Immune Stimulation, and Brain Protection/Regeneration Therapeutic Solutions International, Inc. (TSOI), a clinical-stage stem cell and immunotherapy company, announced today the granting of a patent covering the abi...